Luana Colloca, MD, PhD, and Chris Reist, MD, comment on how clinicians can use placebo and nocebo effects to improve care.
Update focuses on the evaluation, management, and monitoring of those at risk for, or living with, dyslipidemia.
Yen-Yi Juo, MD, MPH, and Michael Doney, MD, discuss the potential use of whole-body MRI–derived body composition z-scores.
Robert J. Fontana, MD, and Kenneth D. Rothstein, MD, share how they deliver self-management education to patients with MASLD.
As wildfire smoke becomes an increasingly common consequence of climate change, clinicians are facing new challenges in ...
Looking for a laugh? This week’s medical cartoon features a famous explorer dealing with persistent directional dysregulation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results